Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Price:
108.62 USD
-0.34%
Market Closed
Updated:
May 21, 2024
Jazz Pharmaceuticals PLC
Research & Development
|
Jazz Pharmaceuticals PLC
Research & Development Peer Comparison
Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Research & Development
-$911.1m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-18%
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Research & Development
-$120.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
2%
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Research & Development
-$12.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-1%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Research & Development
-$29.5m
|
CAGR 3-Years
-343%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Research & Development
-€14.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
2%
|
|
|
Ovoca Bio PLC
LSE:OVB
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Jazz Pharmaceuticals PLC's Research & Development?
Research & Development
-911.1m
USD
-911.1m
USD
Based on the financial report for Mar 31, 2024, Jazz Pharmaceuticals PLC's Research & Development amounts to -911.1m USD.
What is Jazz Pharmaceuticals PLC's Research & Development growth rate?
Research & Development CAGR 10Y
-18%
-18%
Over the last year, the Research & Development growth was 17%. The average annual Research & Development growth rates for Jazz Pharmaceuticals PLC have been -34% over the past three years , -27% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet
